Patents by Inventor Graeme Jones

Graeme Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190316745
    Abstract: The invention proposes a lighting device, in particular an emergency lighting device. The lighting device includes a first housing (2), a lighting means (12), for example an LED arranged at the first housing (2) and an electronic circuitry accommodated in the first housing (2) for operating the lighting means (12). A second housing (3) of the lighting device accommodates an energy storage means (13) such as a rechargeable battery, wherein the first housing (2) and the second housing (3) are arranged spaced apart. An interconnecting means (4) mechanically connects the first housing (2) and the second housing (3) in an elastic manner and also connects electrically the electronic circuitry and the energy storage means (13). The interconnecting means (4) of the lighting device of a preferred embodiment comprises a cable which is overmoulded to provide compressive strength in an axial direction of the cable.
    Type: Application
    Filed: September 27, 2017
    Publication date: October 17, 2019
    Applicant: TRIDONIC GMBH & CO KG
    Inventors: Paul Dalby, Graeme Jones, John Kears, Stephen Parkes, Ian Wilson, John Richardson
  • Publication number: 20190209804
    Abstract: A vent system for use during respiratory therapy with a flow of pressurized gas may provide a continuous vent flow of gas. The vent system may include a vent housing having an outer wall; an inner wall, the inner wall defining an inlet for the flow of gas; and a base positioned between the outer wall and the inner wall, the base having at least one first orifice and at least one second orifice. The vent system may include a membrane, the membrane being shaped and dimensioned such that the membrane does not cover the at least one first orifice to allow the vent flow through the at least one first orifice, and the membrane being shaped and dimensioned such that in a first position the membrane is positioned over the at least one second orifice to allow the vent flow through the at least one second orifice.
    Type: Application
    Filed: September 21, 2017
    Publication date: July 11, 2019
    Inventors: Muditha Pradeep DANTANARAYANA, Charles Harry FINCH, Justin John FORMICA, Richard Llewelyn JONES, Joseph Samuel ORMROD, Jamie Graeme WEHBEH, Chia Ik TAN
  • Publication number: 20180058217
    Abstract: Concrete is formed by providing a wet layer of a first concrete 4, applying a second wet layer 6 of concrete on the first layer 4 of wet concrete and setting the layers 4 and 6 to provide a composite concrete structure, wherein at least one of the layers comprises, AACM (Alkali-Activated Cementitious Material). An ionic bond 2 is formed between the two layers. The AACM layer may comprise a reinforcement structure and cathodic protection.
    Type: Application
    Filed: February 12, 2016
    Publication date: March 1, 2018
    Inventor: Graeme Jones
  • Patent number: 9717747
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: August 1, 2017
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Patent number: 9623038
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: April 18, 2017
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Patent number: 9610300
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: April 4, 2017
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20170079998
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid, can be used to treat or alleviate pain or related conditions such as arthritis.
    Type: Application
    Filed: December 6, 2016
    Publication date: March 23, 2017
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20170079996
    Abstract: Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions such as arthritis.
    Type: Application
    Filed: December 1, 2016
    Publication date: March 23, 2017
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20170079997
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: December 2, 2016
    Publication date: March 23, 2017
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20170071960
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain in conditions such as arthritis.
    Type: Application
    Filed: November 29, 2016
    Publication date: March 16, 2017
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20160331766
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: July 22, 2016
    Publication date: November 17, 2016
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20160331767
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: July 22, 2016
    Publication date: November 17, 2016
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20160113950
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 28, 2016
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20160095871
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: December 11, 2015
    Publication date: April 7, 2016
    Inventors: Herriot Tabuteau, Graeme Jones
  • Patent number: 9289384
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: March 22, 2016
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Patent number: 9289385
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: January 28, 2015
    Date of Patent: March 22, 2016
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Patent number: 9216153
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: December 22, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Patent number: 9211257
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: December 15, 2015
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20150148312
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: January 23, 2015
    Publication date: May 28, 2015
    Inventors: Herriot Tabuteau, Graeme Jones
  • Publication number: 20150141374
    Abstract: Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions.
    Type: Application
    Filed: January 28, 2015
    Publication date: May 21, 2015
    Inventors: Herriot Tabuteau, Graeme Jones